MP
GILD icon

Moment Partners’s Gilead Sciences GILD Stock Holding History

Moment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Hold
1,726
– – 0.04% 97
2026
Q1 		$241K Hold
1,726
– – 0.04% 103
2025
Q4 		$212K Buy
+1,726
New +$210K 0.04% 100

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Moment Partners's GILD Position: Q2 2026 in Review

Moment Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,726 shares worth $218K. The position accounts for 0.04% of the portfolio, ranked #97.

Moment Partners first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $241K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Moment Partners held 1,726 shares of Gilead Sciences worth $218K as of Q2 2026.
  • Moment Partners left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.04% of Moment Partners's portfolio in Q2 2026, its #97 holding.
  • Moment Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Moment Partners's Gilead Sciences position peaked at $241K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Moment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.